Abstract | OBJECTIVE: METHODS: This study included 31 patients with intractable epilepsy and TSC who were treated with the KD, and an intention-to-treat analysis was performed. RESULTS: Overall, 21 of the 31 patients (67.7%) had >50% reduction in seizures at 3 months after initiating the KD. Thirteen of the 31 patients (41.9%) were seizure-free for at least 3 months, but 10 of these 13 patients (76.9%) experienced seizure recurrence during the 24-month follow-up period. Finally, at 24 months of the KD observational period, there was >50% response in 10 of the 31 patients (32.3%), including seizure-free patients (6 of 31 patients, 19.4%). Most of the patients (12 of 13, 92.3%) who experienced seizure freedom had >50% reduction in seizures within 1 month after initiating the KD, and this result was the only factor associated with seizure freedom in the current study. CONCLUSION: The KD appeared to be an effective therapeutic modality for intractable pediatric epilepsy in TSC, but it did not exhibit guaranteed efficacy over a long-term period.
|
Authors | Song Ee Youn, Soyoung Park, Se Hee Kim, Joon Soo Lee, Heung Dong Kim, Hoon-Chul Kang |
Journal | Epilepsy research
(Epilepsy Res)
Vol. 164
Pg. 106348
(08 2020)
ISSN: 1872-6844 [Electronic] Netherlands |
PMID | 32413817
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2020 Elsevier B.V. All rights reserved. |
Topics |
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Diet, Carbohydrate-Restricted
- Diet, Ketogenic
(methods)
- Drug Resistant Epilepsy
(complications, surgery)
- Epilepsy
(complications, surgery)
- Female
- Humans
- Male
- Middle Aged
- Retrospective Studies
- Seizures
(complications, surgery)
- Tuberous Sclerosis
(complications, surgery)
- Young Adult
|